VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 367 filers reported holding VANECK VECTORS ETF TR in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,098,374 | +177.0% | 35,420 | +140.4% | 0.54% | +157.3% |
| Q3 2023 | $396,519 | -14.3% | 14,735 | -4.1% | 0.21% | -10.2% |
| Q2 2023 | $462,490 | -1.4% | 15,360 | +5.9% | 0.24% | -6.7% |
| Q1 2023 | $469,075 | +991.1% | 14,500 | +866.7% | 0.25% | +950.0% |
| Q4 2022 | $42,990 | +19.4% | 1,500 | 0.0% | 0.02% | +14.3% |
| Q3 2022 | $36,000 | -12.2% | 1,500 | 0.0% | 0.02% | -4.5% |
| Q2 2022 | $41,000 | -91.6% | 1,500 | -88.2% | 0.02% | -90.0% |
| Q1 2022 | $486,000 | +912.5% | 12,660 | +744.0% | 0.22% | +947.6% |
| Q4 2021 | $48,000 | +9.1% | 1,500 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $44,000 | -89.9% | 1,500 | -88.3% | 0.02% | -90.0% |
| Q2 2021 | $437,000 | -87.2% | 12,870 | -87.7% | 0.21% | -87.8% |
| Q1 2021 | $3,410,000 | -10.9% | 104,928 | -1.2% | 1.72% | -11.8% |
| Q4 2020 | $3,827,000 | -4.4% | 106,253 | +3.9% | 1.94% | -12.5% |
| Q3 2020 | $4,003,000 | +10.4% | 102,233 | +3.4% | 2.22% | +4.0% |
| Q2 2020 | $3,627,000 | +65.8% | 98,883 | +4.2% | 2.14% | +38.8% |
| Q1 2020 | $2,187,000 | -10.4% | 94,918 | +13.9% | 1.54% | +13.6% |
| Q4 2019 | $2,440,000 | +107.8% | 83,330 | +89.6% | 1.36% | +93.2% |
| Q3 2019 | $1,174,000 | +12.0% | 43,945 | +7.2% | 0.70% | +11.6% |
| Q2 2019 | $1,048,000 | +26.6% | 40,985 | +10.9% | 0.63% | +25.3% |
| Q1 2019 | $828,000 | +34.9% | 36,960 | +27.0% | 0.50% | +19.5% |
| Q4 2018 | $614,000 | +1654.3% | 29,095 | +1439.4% | 0.42% | +1900.0% |
| Q3 2018 | $35,000 | -16.7% | 1,890 | 0.0% | 0.02% | -19.2% |
| Q2 2018 | $42,000 | +223.1% | 1,890 | +215.0% | 0.03% | +225.0% |
| Q1 2018 | $13,000 | -7.1% | 600 | 0.0% | 0.01% | -11.1% |
| Q4 2017 | $14,000 | 0.0% | 600 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $14,000 | +7.7% | 600 | 0.0% | 0.01% | +12.5% |
| Q2 2017 | $13,000 | -7.1% | 600 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $14,000 | +7.7% | 600 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $13,000 | -18.8% | 600 | 0.0% | 0.01% | -18.2% |
| Q3 2016 | $16,000 | -55.6% | 600 | -53.8% | 0.01% | -54.2% |
| Q2 2016 | $36,000 | – | 1,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |